1. Introduction Initially described by Johannes Muller in 1838 as "cystosarcoma phyllodes" [1], the phyllodes tumor (PT) accounts for 0.3–1% of the mammary tumors and 2–3% of the malignant fibroepithelial lesions of the breast [2,3] in middle-aged affected women (age between 40 and 50...